αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Clinical trial NCT04503980 · UNKNOWN
Trial details
- NCT number
- NCT04503980
- Sponsor
- Shanghai Cell Therapy Group Co.,Ltd
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-26
- Primary completion
- 2021-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.